What is the normal range for Amniotic Fluid Index (AFI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Normal Amniotic Fluid Index (AFI) Range

The normal range for Amniotic Fluid Index (AFI) is 5-24 cm, with values below 5 cm indicating oligohydramnios and values above 24 cm or >95th percentile for gestational age indicating polyhydramnios. 1

Understanding AFI Measurement

  • AFI is measured by summing the deepest vertical pocket of amniotic fluid in each of the four quadrants of the uterus, providing a quasi-quantitative assessment of amniotic fluid volume 1
  • Normal amniotic fluid is reassuring, while both oligohydramnios and polyhydramnios are associated with adverse perinatal outcomes 1
  • AFI is an essential component of the modified Biophysical Profile (mBPP) for fetal surveillance 1

Normal AFI Values by Gestational Age

  • AFI values vary throughout pregnancy, with maximal values occurring around 26 weeks of gestation 2
  • The definition of normal AFI varies with gestational age, though 5-24 cm is generally accepted across gestation 1
  • At term (37 weeks or beyond), an AFI of 5 cm or greater is typically considered adequate 1
  • Before 37 weeks, an AFI of 8 cm or greater is commonly used to define normal amniotic fluid 1

Clinical Significance of AFI Values

  • Oligohydramnios (AFI ≤ 5 cm) is associated with:

    • Increased risk of stillbirth (odds ratio 2.6,95% CI 2.1-3.2) 1
    • Higher rates of intrapartum fetal heart rate abnormalities 1
    • Increased risk of cesarean delivery for fetal distress 3
  • Polyhydramnios (AFI > 24 cm or >95th percentile) is associated with:

    • Increased risk of perinatal mortality (odds ratio 5.8,95% CI 3.68-9.11) 1
    • Independent association with stillbirth (odds ratio 1.8,95% CI 1.4-2.2) 1

Volume Considerations

  • The actual volume of amniotic fluid per centimeter of AFI changes during gestation 4
  • At 20 weeks, each centimeter of AFI corresponds to approximately 25 mL of fluid 4
  • At 30 weeks, each centimeter of AFI corresponds to approximately 41 mL of fluid 4
  • At 34 weeks, each centimeter of AFI corresponds to approximately 35 mL of fluid 4

AFI vs. Maximum Vertical Pocket (MVP)

  • Contemporary studies suggest that the Maximum Vertical Pocket (MVP) may perform better than AFI for clinical decision making 1
  • Normal MVP is defined as ≥ 2 cm throughout gestation 1
  • More patients are diagnosed with oligohydramnios using AFI than MVP, resulting in more obstetric interventions 1
  • Neither AFI nor MVP performs better than the other at preventing intrauterine fetal demise 1

Monitoring Recommendations

  • For patients with normal AFI (> 8 cm) at less than 41 weeks gestation, weekly assessments are likely adequate 5
  • For patients with low-normal AFI (5-8 cm) at less than 41 weeks gestation, twice-weekly assessments are recommended due to a higher risk (12.3%) of developing oligohydramnios within 4 days 5
  • For all patients at or beyond 41 weeks gestation, twice-weekly AFI assessments are recommended regardless of the initial measurement 5

Racial/Ethnic Considerations

  • Statistically significant differences in AFI have been observed among different racial/ethnic groups, particularly after 35 weeks gestation 2
  • These differences are most prominent at the extremes of distribution (3rd and 97th percentiles) 2
  • The absolute differences appear small and may not be clinically significant 2

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.